Evaluation of amide replacements in CCR5 antagonists as a means to increase intrinsic permeability. Part 2: SAR optimization and pharmacokinetic profile of a homologous azacyle series

In our CCR5 program, piperidine and azetidine amide replacements as means to improve intrinsic permeability were evaluated. This led to new series of potent CCR5 antagonists, with improved PK behavior. Replacement of a secondary amide with a piperidine or azetidine moiety in a series of CCR5 antagon...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2010-11, Vol.20 (22), p.6802-6807
Hauptverfasser: Wanner, Jutta, Chen, Lijing, Lemoine, Rémy C., Kondru, Rama, Jekle, Andreas, Heilek, Gabrielle, deRosier, André, Ji, Changhua, Berry, Pamela W., Rotstein, David M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6807
container_issue 22
container_start_page 6802
container_title Bioorganic & medicinal chemistry letters
container_volume 20
creator Wanner, Jutta
Chen, Lijing
Lemoine, Rémy C.
Kondru, Rama
Jekle, Andreas
Heilek, Gabrielle
deRosier, André
Ji, Changhua
Berry, Pamela W.
Rotstein, David M.
description In our CCR5 program, piperidine and azetidine amide replacements as means to improve intrinsic permeability were evaluated. This led to new series of potent CCR5 antagonists, with improved PK behavior. Replacement of a secondary amide with a piperidine or azetidine moiety in a series of CCR5 antagonists led to the discovery of compounds with increased intrinsic permeability. This effort led to the identification of a potent CCR5 antagonist which exhibited an improved in vivo pharmacokinetic profile.
doi_str_mv 10.1016/j.bmcl.2010.08.118
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_867749928</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X10012540</els_id><sourcerecordid>867749928</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-2f9a06579f84f318e69ddfdba0abb675c5f089b569ddbb2319c336b68a4c3d793</originalsourceid><addsrcrecordid>eNqFkV9rFDEUxQdR7Fr9Aj5IXsSnXfNvZhLxpSy1FQpKVfAt3MncabPOJGuSLWy_mF_PjLvqm0Ig4eR3Tw45VfWc0RWjrHm9WXWTHVecFoGqFWPqQbVgspFLIWn9sFpQ3dCl0vLrSfUkpQ2lTFIpH1cnnKq65owvqh_ndzDuILvgSRgITK5HEnE7gsUJfU7EebJeX9cEfIab4F0qGpRFJgSfSA6FsBEhYTnk6HxylmwxluvOjS7vV-QjxEz4G_Lp7JqEbXaTuz-8CL4n21uIE9jwzXnM82gMgxvxVxpyG6YwhpuwKw_eg90XPWF0mJ5WjwYYEz477qfVl3fnn9eXy6sPF-_XZ1dLK1mbl3zQQJu61YOSg2AKG933Q98Bha5r2trWA1W6q2e567hg2grRdI0CaUXfanFavTr4lljfd5iymVyyOI7gsaQyqmlbqTVX_yXbWgtezEUh-YG0MaQUcTDb6CaIe8OomZs1GzM3a-ZmDVWmNFuGXhztd92E_Z-R31UW4OURgGRhHCJ469JfTghdczUbvT1wWL7tzmE0yTr0FnsX0WbTB_evHD8BC6TFJw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>759323363</pqid></control><display><type>article</type><title>Evaluation of amide replacements in CCR5 antagonists as a means to increase intrinsic permeability. Part 2: SAR optimization and pharmacokinetic profile of a homologous azacyle series</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Wanner, Jutta ; Chen, Lijing ; Lemoine, Rémy C. ; Kondru, Rama ; Jekle, Andreas ; Heilek, Gabrielle ; deRosier, André ; Ji, Changhua ; Berry, Pamela W. ; Rotstein, David M.</creator><creatorcontrib>Wanner, Jutta ; Chen, Lijing ; Lemoine, Rémy C. ; Kondru, Rama ; Jekle, Andreas ; Heilek, Gabrielle ; deRosier, André ; Ji, Changhua ; Berry, Pamela W. ; Rotstein, David M.</creatorcontrib><description>In our CCR5 program, piperidine and azetidine amide replacements as means to improve intrinsic permeability were evaluated. This led to new series of potent CCR5 antagonists, with improved PK behavior. Replacement of a secondary amide with a piperidine or azetidine moiety in a series of CCR5 antagonists led to the discovery of compounds with increased intrinsic permeability. This effort led to the identification of a potent CCR5 antagonist which exhibited an improved in vivo pharmacokinetic profile.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2010.08.118</identifier><identifier>PMID: 20855212</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ltd</publisher><subject>Amides - chemistry ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral agents ; Aza Compounds - chemistry ; Aza Compounds - pharmacokinetics ; Aza Compounds - pharmacology ; Biological and medical sciences ; CCR5 antagonist ; CCR5 Receptor Antagonists ; HIV entry inhibition ; Medical sciences ; Permeability ; Pharmacology. Drug treatments ; Structure-Activity Relationship</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2010-11, Vol.20 (22), p.6802-6807</ispartof><rights>2010 Elsevier Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2010 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-2f9a06579f84f318e69ddfdba0abb675c5f089b569ddbb2319c336b68a4c3d793</citedby><cites>FETCH-LOGICAL-c417t-2f9a06579f84f318e69ddfdba0abb675c5f089b569ddbb2319c336b68a4c3d793</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0960894X10012540$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23395288$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20855212$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wanner, Jutta</creatorcontrib><creatorcontrib>Chen, Lijing</creatorcontrib><creatorcontrib>Lemoine, Rémy C.</creatorcontrib><creatorcontrib>Kondru, Rama</creatorcontrib><creatorcontrib>Jekle, Andreas</creatorcontrib><creatorcontrib>Heilek, Gabrielle</creatorcontrib><creatorcontrib>deRosier, André</creatorcontrib><creatorcontrib>Ji, Changhua</creatorcontrib><creatorcontrib>Berry, Pamela W.</creatorcontrib><creatorcontrib>Rotstein, David M.</creatorcontrib><title>Evaluation of amide replacements in CCR5 antagonists as a means to increase intrinsic permeability. Part 2: SAR optimization and pharmacokinetic profile of a homologous azacyle series</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>In our CCR5 program, piperidine and azetidine amide replacements as means to improve intrinsic permeability were evaluated. This led to new series of potent CCR5 antagonists, with improved PK behavior. Replacement of a secondary amide with a piperidine or azetidine moiety in a series of CCR5 antagonists led to the discovery of compounds with increased intrinsic permeability. This effort led to the identification of a potent CCR5 antagonist which exhibited an improved in vivo pharmacokinetic profile.</description><subject>Amides - chemistry</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral agents</subject><subject>Aza Compounds - chemistry</subject><subject>Aza Compounds - pharmacokinetics</subject><subject>Aza Compounds - pharmacology</subject><subject>Biological and medical sciences</subject><subject>CCR5 antagonist</subject><subject>CCR5 Receptor Antagonists</subject><subject>HIV entry inhibition</subject><subject>Medical sciences</subject><subject>Permeability</subject><subject>Pharmacology. Drug treatments</subject><subject>Structure-Activity Relationship</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkV9rFDEUxQdR7Fr9Aj5IXsSnXfNvZhLxpSy1FQpKVfAt3MncabPOJGuSLWy_mF_PjLvqm0Ig4eR3Tw45VfWc0RWjrHm9WXWTHVecFoGqFWPqQbVgspFLIWn9sFpQ3dCl0vLrSfUkpQ2lTFIpH1cnnKq65owvqh_ndzDuILvgSRgITK5HEnE7gsUJfU7EebJeX9cEfIab4F0qGpRFJgSfSA6FsBEhYTnk6HxylmwxluvOjS7vV-QjxEz4G_Lp7JqEbXaTuz-8CL4n21uIE9jwzXnM82gMgxvxVxpyG6YwhpuwKw_eg90XPWF0mJ5WjwYYEz477qfVl3fnn9eXy6sPF-_XZ1dLK1mbl3zQQJu61YOSg2AKG933Q98Bha5r2trWA1W6q2e567hg2grRdI0CaUXfanFavTr4lljfd5iymVyyOI7gsaQyqmlbqTVX_yXbWgtezEUh-YG0MaQUcTDb6CaIe8OomZs1GzM3a-ZmDVWmNFuGXhztd92E_Z-R31UW4OURgGRhHCJ469JfTghdczUbvT1wWL7tzmE0yTr0FnsX0WbTB_evHD8BC6TFJw</recordid><startdate>20101115</startdate><enddate>20101115</enddate><creator>Wanner, Jutta</creator><creator>Chen, Lijing</creator><creator>Lemoine, Rémy C.</creator><creator>Kondru, Rama</creator><creator>Jekle, Andreas</creator><creator>Heilek, Gabrielle</creator><creator>deRosier, André</creator><creator>Ji, Changhua</creator><creator>Berry, Pamela W.</creator><creator>Rotstein, David M.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20101115</creationdate><title>Evaluation of amide replacements in CCR5 antagonists as a means to increase intrinsic permeability. Part 2: SAR optimization and pharmacokinetic profile of a homologous azacyle series</title><author>Wanner, Jutta ; Chen, Lijing ; Lemoine, Rémy C. ; Kondru, Rama ; Jekle, Andreas ; Heilek, Gabrielle ; deRosier, André ; Ji, Changhua ; Berry, Pamela W. ; Rotstein, David M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-2f9a06579f84f318e69ddfdba0abb675c5f089b569ddbb2319c336b68a4c3d793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Amides - chemistry</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral agents</topic><topic>Aza Compounds - chemistry</topic><topic>Aza Compounds - pharmacokinetics</topic><topic>Aza Compounds - pharmacology</topic><topic>Biological and medical sciences</topic><topic>CCR5 antagonist</topic><topic>CCR5 Receptor Antagonists</topic><topic>HIV entry inhibition</topic><topic>Medical sciences</topic><topic>Permeability</topic><topic>Pharmacology. Drug treatments</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wanner, Jutta</creatorcontrib><creatorcontrib>Chen, Lijing</creatorcontrib><creatorcontrib>Lemoine, Rémy C.</creatorcontrib><creatorcontrib>Kondru, Rama</creatorcontrib><creatorcontrib>Jekle, Andreas</creatorcontrib><creatorcontrib>Heilek, Gabrielle</creatorcontrib><creatorcontrib>deRosier, André</creatorcontrib><creatorcontrib>Ji, Changhua</creatorcontrib><creatorcontrib>Berry, Pamela W.</creatorcontrib><creatorcontrib>Rotstein, David M.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wanner, Jutta</au><au>Chen, Lijing</au><au>Lemoine, Rémy C.</au><au>Kondru, Rama</au><au>Jekle, Andreas</au><au>Heilek, Gabrielle</au><au>deRosier, André</au><au>Ji, Changhua</au><au>Berry, Pamela W.</au><au>Rotstein, David M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of amide replacements in CCR5 antagonists as a means to increase intrinsic permeability. Part 2: SAR optimization and pharmacokinetic profile of a homologous azacyle series</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2010-11-15</date><risdate>2010</risdate><volume>20</volume><issue>22</issue><spage>6802</spage><epage>6807</epage><pages>6802-6807</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>In our CCR5 program, piperidine and azetidine amide replacements as means to improve intrinsic permeability were evaluated. This led to new series of potent CCR5 antagonists, with improved PK behavior. Replacement of a secondary amide with a piperidine or azetidine moiety in a series of CCR5 antagonists led to the discovery of compounds with increased intrinsic permeability. This effort led to the identification of a potent CCR5 antagonist which exhibited an improved in vivo pharmacokinetic profile.</abstract><cop>Amsterdam</cop><pub>Elsevier Ltd</pub><pmid>20855212</pmid><doi>10.1016/j.bmcl.2010.08.118</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2010-11, Vol.20 (22), p.6802-6807
issn 0960-894X
1464-3405
language eng
recordid cdi_proquest_miscellaneous_867749928
source MEDLINE; Elsevier ScienceDirect Journals
subjects Amides - chemistry
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antiviral agents
Aza Compounds - chemistry
Aza Compounds - pharmacokinetics
Aza Compounds - pharmacology
Biological and medical sciences
CCR5 antagonist
CCR5 Receptor Antagonists
HIV entry inhibition
Medical sciences
Permeability
Pharmacology. Drug treatments
Structure-Activity Relationship
title Evaluation of amide replacements in CCR5 antagonists as a means to increase intrinsic permeability. Part 2: SAR optimization and pharmacokinetic profile of a homologous azacyle series
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T00%3A05%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20amide%20replacements%20in%20CCR5%20antagonists%20as%20a%20means%20to%20increase%20intrinsic%20permeability.%20Part%202:%20SAR%20optimization%20and%20pharmacokinetic%20profile%20of%20a%20homologous%20azacyle%20series&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Wanner,%20Jutta&rft.date=2010-11-15&rft.volume=20&rft.issue=22&rft.spage=6802&rft.epage=6807&rft.pages=6802-6807&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2010.08.118&rft_dat=%3Cproquest_cross%3E867749928%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=759323363&rft_id=info:pmid/20855212&rft_els_id=S0960894X10012540&rfr_iscdi=true